跳至主要内容
临床试验/NCT01914146
NCT01914146撤回不适用

Insulin Therapy and Falls Due to Orthostatic Hypotension (Pilot Study)

University of British Columbia2 个研究点 分布在 1 个国家开始时间: 2015年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
1. Presence or absence of orthostatic hypotension

研究概览

简要总结

In the proposed study, the investigators examine in older adults with Type 2 diabetes the impact of beginning insulin therapy on the orthostatic drop in blood pressure as well as the response of arterial blood pressure and Doppler measures of cerebral blood flow during upright tilt. The investigators hypothesize that in older adults with Type 2 diabetes, the cardiovascular effects of insulin would precipitate or worsen orthostatic intolerance not present at baseline.

详细描述

Before and 2 weeks after the start of standard insulin therapy several tests will be done:

  • orthostatic hypotension will be tested for with 3 orthostatic maneuvers
  • vasovagal syncope will be tested with 2 tilt table tests, one augmented with 400ug of nitroglycerin
  • MCA velocity will be measured with a transcranial doppler
  • Heart Rate and Blood Pressure will be measured throughout the test with a Finometer and Power Lab on a beat to beat basis

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • All subjects must be 65 years of age or older
  • All must have been diagnosed with Type 2 diabetes for at least 5 years
  • All subjects must be insulin-naïve on recruitment
  • All subjects must be eligible to start insulin therapy (long or intermediate acting) as determined by their diabetologist

排除标准

  • Anemia, as determined by serum hematocrit
  • Abnormal liver function tests
  • Elevated creatinine
  • Musculoskeletal or neurological condition that would preclude tilt table testing or orthostatic vitals

研究组 & 干预措施

Before Initiation of Insulin Therapy

Other

Study sessions will occur before the initiation of insulin therapy (no insulin). Initiation of insulin administration will be determined as part of standard of care by the subjects diabetologist in the VGH Diabetes Centre and not as part of participation in this study.

干预措施: No Insulin (Other)

After Initiation of Insulin Therapy

Other

Study session will take place 2-4 weeks after the initiation of insulin therapy. Initiation of insulin administration will be determined as part of standard of care by the subjects diabetologist in the VGH Diabetes Centre and not as part of participation in this study.

干预措施: Insulin (Other)

结局指标

主要结局

1. Presence or absence of orthostatic hypotension

时间窗: 1 day

defined as a drop in systolic blood pressure greater than 20 mmHg after 3 minutes upright standing

次要结局

  • 3. The nadir of systolic blood pressure (SBP) and diastolic blood pressure (DBP) during tilt table test.(1 day)
  • 1. The nadir of middle cerebral artery (MCA) velocity(1 day)
  • 2. The presence or absence of a positive augmented tilt table test(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kenneth Madden

Principal Investigator

University of British Columbia

研究点 (2)

Loading locations...

相似试验